Supplemental Appendix 2: Concurrence with Institute of Medicine standards for systematic reviews and for guidelines. Supplementary material is linked to the online version of the paper at http://www.kdigo.org/home/guidelines/lipids methods for guideline development Biographic and disclosure information Marcello A Tonelli, MD, SM, FRCPC (Work Group Co-Chair), received an MD from the University of Western Ontario, specialist certification in nephrology (FRCPC) at Dalhousie University, and an SM in epidemio- logy from Harvard University. He is a nephrologist and Associate Professor at the University of Alberta. He serves as Associate Editor of American Journal of Kidney Diseases, the Cochrane Renal Group and the Journal of Nephrology, and is a member of the Editorial Board for Journal of the American Society of Nephrology. Dr. Tonelli is the President of the Canadian Society of Nephrology, a Councillor of the International Society of Nephrology and a past member of the Minister s Expert Committee for Drug Evaluation for the Province of Alberta. In March 2010, Dr. Tonelli was named the chair of the Canadian Task Force for Preventive Health Care, a national panel of experts that will make recommen- dations about preventive health services to Canada s more than 36,000 family physicians. Dr. Tonelli holds a Health Scholar award from the Alberta Heritage Foundation for Medical Research (AHFMR) and a Canada Research Chair in the optimal care of people with CKD. He is a founding member of the Alberta Kidney Disease Network and co-leader of the AHFMR Interdisciplinary Chronic Disease Collaboration (ICDC) research team. Since 2005, Dr. Tonelli has been the co-leader of a joint initiative between the University of Alberta and the Hospital Civil de Guadalajara, aimed at prevention of kidney failure among the poor of Jalisco, Mexico. 